These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 3258956)

  • 1. Mucosal immune response to cholera toxin--cellular basis of memory and adjuvant action.
    Lycke N; Holmgren J
    Monogr Allergy; 1988; 24():274-81. PubMed ID: 3258956
    [No Abstract]   [Full Text] [Related]  

  • 2. Stimulation of antigen-specific T- and B-cell memory in local as well as systemic lymphoid tissues following oral immunization with cholera toxin adjuvant.
    Vajdy M; Lycke N
    Immunology; 1993 Oct; 80(2):197-203. PubMed ID: 7505255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strong adjuvant properties of cholera toxin on gut mucosal immune responses to orally presented antigens.
    Lycke N; Holmgren J
    Immunology; 1986 Oct; 59(2):301-8. PubMed ID: 3021614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulating dendritic cells to optimize mucosal immunization protocols.
    Williamson E; Westrich GM; Viney JL
    J Immunol; 1999 Oct; 163(7):3668-75. PubMed ID: 10490961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Presence of antigen-specific long-term memory cells in systemic lymphoid tissues as well as locally in the gut lamina propria following oral immunization with cholera toxin adjuvant.
    Vajdy M; Lycke N
    Adv Exp Med Biol; 1995; 371B():1495-500. PubMed ID: 7502844
    [No Abstract]   [Full Text] [Related]  

  • 6. Strategies for the induction of immune responses at mucosal surfaces making use of cholera toxin B subunit as immunogen, carrier, and adjuvant.
    Holmgren J; Czerkinsky C; Lycke N; Svennerholm AM
    Am J Trop Med Hyg; 1994; 50(5 Suppl):42-54. PubMed ID: 8203723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Live varicella vaccine polarizes the mucosal adjuvant action of cholera toxin or its B subunit on specific Th1-type helper T cells with a single nasal coadministration in mice.
    Sasaki K; Kato M; Takahashi T; Ochi S; Ichinose Y; Shiraki K; Asano Y; Iwanaga M; Tsuji T
    J Med Virol; 2003 Jun; 70(2):329-35. PubMed ID: 12696126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adoptive transfer of gut mucosal antitoxin memory by isolated B cells 1 year after oral immunization with cholera toxin.
    Lycke N; Holmgren J
    Infect Immun; 1989 Apr; 57(4):1137-41. PubMed ID: 2784416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD8-deficient mice exhibit augmented mucosal immune responses and intact adjuvant effects to cholera toxin.
    Hörnquist E; Grdic D; Mak T; Lycke N
    Immunology; 1996 Feb; 87(2):220-9. PubMed ID: 8698383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parenteral immunization causes antigen-specific cell-mediated suppression of an intestinal IgA response.
    Koster FT; Pierce NF
    J Immunol; 1983 Jul; 131(1):115-9. PubMed ID: 6190901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A two-codon mutant of cholera toxin lacking ADP-ribosylating activity functions as an effective adjuvant for eliciting mucosal and systemic cellular immune responses to peptide antigens.
    Lomada D; Gambhira R; Nehete PN; Guhad FA; Chopra AK; Peterson JW; Sastry KJ
    Vaccine; 2004 Dec; 23(4):555-65. PubMed ID: 15530705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The B-cell targeted CTA1-DD vaccine adjuvant is highly effective at enhancing antibody as well as CTL responses.
    Lycke N
    Curr Opin Mol Ther; 2001 Feb; 3(1):37-44. PubMed ID: 11249730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mucosal memory B cells retain the ability to produce IgM antibodies 2 years after oral immunization.
    Vajdy M; Lycke N
    Immunology; 1995 Nov; 86(3):336-42. PubMed ID: 8550068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maintenance of long-term immunological memory by low avidity IgM-secreting cells in bone marrow after mucosal immunizations with cholera toxin adjuvant.
    Soenawan E; Srivastava I; Gupta S; Kan E; Janani R; Kazzaz J; Singh M; Shreedhar V; Vajdy M
    Vaccine; 2004 Mar; 22(11-12):1553-63. PubMed ID: 15063581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful priming and tolerization of T cells to orally administered antigens in B-cell-deficient mice.
    Hashimoto A; Yamada H; Matsuzaki G; Nomoto K
    Cell Immunol; 2001 Jan; 207(1):36-40. PubMed ID: 11161451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholera toxin enhances antigen presentation.
    Bromander AK; Kjerrulf M; Holmgren J; Lycke N
    Adv Exp Med Biol; 1995; 371B():1501-6. PubMed ID: 7502845
    [No Abstract]   [Full Text] [Related]  

  • 17. Cellular dissemination of priming for a mucosal immune response to cholera toxin in rats.
    Pierce NF; Cray WC
    J Immunol; 1981 Dec; 127(6):2461-4. PubMed ID: 7299131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in specific B cells and the dissemination of the primed state in vivo following antigenic stimulation by different mucosal routes.
    Cebra JJ; Fuhrman JA; Griffin P; Rose FV; Schweitzer PA; Zimmerman D
    Ann Allergy; 1984 Dec; 53(6 Pt 2):541-9. PubMed ID: 6209998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Migration of antigen-presenting B cells from peripheral to mucosal lymphoid tissues may induce intestinal antigen-specific IgA following parenteral immunization.
    Coffin SE; Clark SL; Bos NA; Brubaker JO; Offit PA
    J Immunol; 1999 Sep; 163(6):3064-70. PubMed ID: 10477570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of epitope-specific cellular immune responses by immunization with HIV-1 peptides genetically conjugated to the B-subunit of recombinant cholera toxin.
    Boberg A; Gaunitz S; Bråve A; Wahren B; Carlin N
    Vaccine; 2008 Sep; 26(40):5079-82. PubMed ID: 18514370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.